| |
|
Form Serial Number: |
DA20261006E00055
|
| 1.
Date of relevant event: |
30/09/2026 (dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01609 |
| 4.
Name of listed corporation: |
北京天星醫療股份有限公司 - H股 |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
54,831,344 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
DONG |
| (Other names) |
WENXING |
|
|
|
| 10.
Name of director (Chinese): |
董文興 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1113 | The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) | |
13,000 |
HKD |
81.8000 |
77.3969 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 19,276,562 | 35.16 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 19,289,562 | 35.18 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 天津鉑康科技有限公司 | 天津市武清區京津電子商務產業園巨集旺道2號14號樓216室01號 | 董文興 | 99.00 | N | |
| 天津普合企業管理諮詢合夥企業(有限合夥) | 天津市武清區京津電子商務產業園巨集旺道2號14號樓218室08號 | 天津鉑康科技有限公司 | 100.00 | Y | |
| 天津吉康企業管理諮詢合夥企業(有限合夥) | 天津市武清區京津電子商務產業園巨集旺道2號14號樓217室03號 | 天津鉑康科技有限公司 | 100.00 | Y | |
| 天津運康科技中心(有限合夥) | 天津市武清區梅廠鎮福源經濟區開源路18號綜合辦公樓1209室 | 天津鉑康科技有限公司 | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
第24欄:本表格用於反映公司根據回購授權在公開市場回購的13,000股H股庫存股份,截至2026年9月30日,這些股份將作為庫存股份持有。第27欄:由於董文興先生直接或間接控制公司股東大會三分之一或以上的表決權,根據《證券及期貨條例》,他被視為對公司上述41,700股H股庫存股份擁有權益。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
06/10/2026 (dd/mm/yyyy)
|
| |